Table 2.
Class I and II HLA often associated with psoriasis vulgaris (PV) and geographic tongue (GT) in population studies (p <0.05)
| Reference | Country | Sample | Class I HLA (OR) | Class II HLA (OR) | HLA typing methods | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PV | GT | C | PV | GT | PV | GT | |||||
| Marks &Taitt (1980)49 | Australia | - | 95 | - | B15 | - | - | Serological | |||
| Fenerli et al.(1993)50 | Greece | - | 50 | 380 | - | - | - | DR5 (2.2)* | Serological | ||
| DRw6 (3.3)* | |||||||||||
| Gonzaga et al. (1996)19 | Brazil | 22 | 32 | 159 | Cw6 (10.0)* | Cw6 (5.4)* | - | - | Serological | ||
| B17 (10.1)* | |||||||||||
| B13 (6.8)* | B13 (5.7)* | ||||||||||
| Enerback et al. (1997)58 | Sweden | 201 | - | 77 | Cw*06 | - | - | - | Molecular | ||
| Kim et al.(2000)59 | Korea | 84 | - | 98 | A1 (17.0)* | - | DRB1*07 (5.9)* | - | Serological | ||
| A30 (5.5)* | DRB1*10 (26.4)* | Molecular | |||||||||
| B13 (5.6)* | DQA1*02 (6.2)* | ||||||||||
| B37 (30.3)* Cw*0602 (36.0)* | DPB1*1701 (24.6)* | ||||||||||
| Zhang et al.(2004)60 | China | 189 | - | 273 | - | - | DQA1*0104 (2.3) | - | Molecular | ||
| DQA1*0201 (3.4) | |||||||||||
| Magalhães et al. (2010)61 | Brazil | 69 | - | 70 | B57 (5.3) | - | DRB1*07 (2.7) | - | Molecular | ||
| Cw6 (3.9) | |||||||||||
| Cw12 (3.8) | |||||||||||
| Shawkatová et al. (2013)62 | Slovakia | 147 | - | 194 | C*06 (3.8) | - | DRB1*07 (2.6) | - | Molecular | ||
| DQB1*02 (1.1) | |||||||||||
C – Control group;
*
RR – Relative Risk; OR - odds ratio; Confidence interval 95%